Holen Sie sich die Stockscreener-App
2.09
0.00%
0.00
In 8 Bio Inc Aktie (INAB) Neueste Nachrichten
Cabaletta Bio, Inc. $CABA Shares Purchased by Acadian Asset Management LLC - MarketBeat
INmune Bio, Inc. (NASDAQ:INMB) Short Interest Down 29.8% in August - MarketBeat
Layoff Tracker: Arvinas Downsizes by 15% After Punting Pfizer-Partnered Asset - BioSpace
Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - BioSpace
Is KALA BIO Inc. stock ready for a breakoutEarnings Recap Report & Long-Term Safe Investment Plans - newser.com
Kalexo enters dyslipidemia fray with preclinical siRNA candidate - BioWorld MedTech
bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Foundational Roots - Business Wire
100% Clinical Response: Palisade Bio's Novel UC Drug Shows Promise in Phase 1b with Zero Serious Side Effects - Stock Titan
Can Palisade Bio Inc. recover in the next quarter2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
Passage Bio Inc. stock retracement – recovery analysisMarket Risk Report & Safe Entry Momentum Stock Tips - newser.com
Pattern recognition hints at Boundless Bio Inc. upsideJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Does Climb Bio Inc. show high probability of reboundJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Can GRI Bio Inc. recover in the next quarterGlobal Markets & High Accuracy Buy Signal Tips - newser.com
Will GRI Bio Inc. continue its uptrend2025 Year in Review & Stock Portfolio Risk Control - newser.com
Gossamer Bio, Inc. (NASDAQ:GOSS) Receives $8.50 Average Price Target from Brokerages - Defense World
First-Ever Phase 3 Trial for Stargardt Disease: Belite Bio's Tinlarebant Could Be Breakthrough Treatment - Stock Titan
Gossamer Bio stock upgraded at UBS (GOSS:NASDAQ) - Seeking Alpha
Novartis to acquire Tourmaline Bio for $1.4 billion - Reuters
Tourmaline Bio to Be Acquired by Novartis; $47.95M Termination Fee, Option Cashouts - Stock Titan
Remedium Bio Announces Strategic Collaboration With Lilly to Develop Gene Therapies for Obesity and Type 2 Diabetes - biospace.com
KALA BIO Soars 10.65% on Bullish Analyst Coverage - AInvest
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Does Gossamer Bio Inc. align with a passive investing strategyJuly 2025 Analyst Calls & Weekly High Conviction Ideas - خودرو بانک
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025 - GlobeNewswire
Rare Eye Disease Biotech KALA BIO to Present Latest Developments at H.C. Wainwright Conference - Stock Titan
KALA BIO to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Canopy Growth, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director - GlobeNewswire
Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Globe and Mail
Gamma Delta T Cell Therapy Pioneer Adicet Bio to Showcase Latest Developments at Global Investment Conference - Stock Titan
First-in-Class TSLP Antibody Results: Upstream Bio's Verekitug Phase 2 Trial in Nasal Polyps Coming - Stock Titan
Signal strength of KALA BIO Inc. stock in tech scannersJuly 2025 Recap & Weekly Market Pulse Alerts - Newser
Is Palisade Bio Inc. trending in predictive chart modelsMarket Sentiment Review & Weekly Hot Stock Watchlists - Newser
Historical volatility pattern of GRI Bio Inc. visualizedDay Trade & Fast Momentum Entry Tips - Newser
Will a bounce in Instil Bio Inc. offer an exit2025 Biggest Moves & AI Powered Buy and Sell Recommendations - Newser
TELA Bio Inc. stock momentum explainedJuly 2025 Patterns & Stock Market Timing Techniques - Newser
Understanding Instil Bio Inc.’s price movementMarket Growth Review & Safe Swing Trade Setups - Newser
Regression analysis insights on GRI Bio Inc. performanceJuly 2025 Review & Fast Gaining Stock Reports - Newser
How to forecast Passage Bio Inc. trends using time series2025 Market WrapUp & Free Real-Time Market Sentiment Alerts - Newser
84,000 Shares at $0.72: Adicet Bio's Latest Inducement Grants Under Nasdaq Rule 5635(c)(4) - Stock Titan
Smart tools for monitoring KALA BIO Inc.’s price actionAnalyst Upgrade & Proven Capital Preservation Tips - Newser
PAH Drug Developer Gossamer Bio Set for Key Presentations at Cantor, Wells Fargo, HC Wainwright Events - Stock Titan
Is Nuvation Bio Inc. stock poised for growthJuly 2025 Breakouts & AI Optimized Trade Strategies - Newser
Trend analysis for Adicet Bio Inc. this weekBull Run & Stock Timing and Entry Methods - Newser
What candlestick patterns are forming on bluebird bio Inc.Stop Loss & Free AI Powered Buy and Sell Recommendations - Newser
What’s next for INmune Bio Inc. stock priceWeekly Trade Review & Entry Point Confirmation Signals - Newser
Genetic Medicines Pioneer Passage Bio to Showcase Neurodegenerative Disease Pipeline at Global Conference - Stock Titan
Visualizing Third Harmonic Bio Inc. stock with heatmaps2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Global Oncology Company Nuvation Bio Announces Triple Conference Schedule for September 2025 - Stock Titan
Is now a turning point for Adicet Bio Inc.Weekly Risk Summary & Daily Oversold Stock Bounce Ideas - Newser
Clinical-Stage Biotech Belite Bio Secures Speaking Slots at Three Premier Healthcare Conferences - Stock Titan
Live market analysis of Third Harmonic Bio Inc.2025 Market Trends & Scalable Portfolio Growth Methods - Newser
H.C. Wainwright Reiterates a Buy Rating on Nuvation Bio (NUVB) - MSN
Combining price and volume data for Nuvation Bio Inc.Dip Buying & Safe Swing Trade Setups - Newser
GRI Bio Inc. stock prediction for this weekQuarterly Trade Report & Daily Stock Trend Reports - Newser
Is Palisade Bio Inc. stock ready for a breakoutBear Alert & Low Drawdown Momentum Trade Ideas - Newser
Palisade Bio Releases Virtual Investor KOL Connect Segment on FSCD and Lead Candidate PALI-2108 - GlobeNewswire
Stop Loss: Is Upstream Bio Inc. forming a double bottomJuly 2025 Chart Watch & Risk Controlled Stock Pick Alerts - theviewers.co.kr
Mustang Bio Inc. stock trend forecastJuly 2025 Summary & Verified Momentum Watchlists - Newser
Volume spikes in Palisade Bio Inc. stock – what they meanWeekly Market Outlook & Precise Swing Trade Alerts - Newser
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):